Peter J Barris - Net Worth and Insider Trading
Peter J Barris Net Worth
The estimated net worth of Peter J Barris is at least $2.5 Billion dollars as of 2024-04-16. Peter J Barris is the 10% Owner of Tesaro Inc and owns about 10,422,179 shares of Tesaro Inc (TSRO) stock worth over $781 Million. Peter J Barris is the 10% Owner of iShares Indl/Office Real Estate Capped and owns about 13,610,551 shares of iShares Indl/Office Real Estate Capped (FNIO) stock worth over $434 Million. Peter J Barris is also the 10% Owner of Supernus Pharmaceuticals Inc and owns about 7,716,055 shares of Supernus Pharmaceuticals Inc (SUPN) stock worth over $230 Million. Besides these, Peter J Barris also holds Rhythm Pharmaceuticals Inc (RYTM) , Ra Pharmaceuticals Inc (RARX) , Mirum Pharmaceuticals Inc (MIRM) , Adaptimmune Therapeutics PLC (ADAP) , Ardelyx Inc (ARDX) , Echo Global Logistics Inc (ECHO) , Boingo Wireless Inc (WIFI) , Amicus Therapeutics Inc (FOLD) , AVEO Pharmaceuticals Inc (AVEO) , Liquidia Corp (LQDA) , Mersana Therapeutics Inc (MRSN) , GlycoMimetics Inc (GLYC) , Millennial Media Inc (MM) , InnerWorkings Inc (INWK) , Senseonics Holdings Inc (SENS) , Trevi Therapeutics Inc (TRVI) , Epizyme Inc (EPZM) , Tableau Software Inc (DATA) , Surface Oncology Inc (SURF) , Regulus Therapeutics Inc (RGLS) , Groupon Inc (GRPN) , Catalyst Biosciences Inc (CBIO) , Dermira Inc (DERM) , Interleukin Genetics Inc (ILIU) , Achaogen Inc (AKAOQ) , Clovis Oncology Inc (CLVSQ) , TRACON Pharmaceuticals Inc (TCON) , Genocea Biosciences Inc (GNCAQ) , Novation Companies Inc (NOVCQ) , ARCA biopharma Inc (ABIO) , Appian Corp (APPN) . Details can be seen in Peter J Barris's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Peter J Barris has not made any transactions after 2019-12-26 and currently still holds the listed stock(s).
Transaction Summary of Peter J Barris
Peter J Barris Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Peter J Barris owns 86 companies in total, including Sprout Social Inc () , Groupon Inc () , and Regulus Therapeutics Inc () among others .
Click here to see the complete history of Peter J Barris’s form 4 insider trades.
Insider Ownership Summary of Peter J Barris
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
Sprout Social Inc | 2019-12-12 | director & 10 percent owner | |
Groupon Inc | 2019-12-26 | director & 10 percent owner | |
Regulus Therapeutics Inc | 2019-05-07 | 10 percent owner | |
Ardelyx Inc | 2016-07-18 | 10 percent owner | |
Proteostasis Therapeutics Inc | 2019-11-26 | 10 percent owner | |
Galera Therapeutics Inc | 2019-11-06 | 10 percent owner | |
Oyster Point Pharma Inc | 2019-10-30 | 10 percent owner | |
Cloudflare Inc | 2019-09-12 | 10 percent owner | |
Mirum Pharmaceuticals Inc | 2019-07-22 | 10 percent owner | |
Genocea Biosciences Inc | 2019-06-24 | 10 percent owner | |
Nightstar Therapeutics PLC | 2019-06-07 | 10 percent owner | |
Trevi Therapeutics Inc | 2019-05-09 | 10 percent owner | |
AVEO Pharmaceuticals Inc | 2019-04-08 | 10 percent owner | |
Mersana Therapeutics Inc | 2017-07-03 | 10 percent owner | |
Tesaro Inc | 2019-01-22 | 10 percent owner | |
Ra Pharmaceuticals Inc | 2018-12-14 | 10 percent owner | |
Millendo Therapeutics Inc | 2018-12-07 | 10 percent owner | |
PhaseBio Pharmaceuticals Inc | 2018-10-17 | 10 percent owner | |
Marker Therapeutics Inc | 2018-10-17 | 10 percent owner | |
Elastic NV | 2018-10-04 | 10 percent owner | |
Adaptimmune Therapeutics PLC | 2018-09-07 | 10 percent owner | |
Liquidia Corp | 2018-07-30 | 10 percent owner | |
Bloom Energy Corp | 2018-07-24 | 10 percent owner | |
GlycoMimetics Inc | 2018-05-10 | 10 percent owner | |
MuleSoft Inc | 2018-05-01 | 10 percent owner | |
Surface Oncology Inc | 2018-04-23 | 10 percent owner | |
TRACON Pharmaceuticals Inc | 2018-03-27 | 10 percent owner | |
Cascadian Therapeutics Inc | 2018-03-09 | 10 percent owner | |
ARCA biopharma Inc | 2018-02-26 | 10 percent owner | |
Tintri Inc | 2018-02-26 | 10 percent owner | |
Appian Corp | 2017-11-27 | 10 percent owner | |
Synlogic Inc | 2015-09-30 | 10 percent owner | |
Strongbridge Biopharma PLC | 2018-01-01 | 10 percent owner | |
Senseonics Holdings Inc | 2017-12-08 | 10 percent owner | |
X4 Pharmaceuticals Inc | 2017-11-20 | 10 percent owner | |
Care.com Inc | 2017-11-06 | 10 percent owner | |
Rhythm Pharmaceuticals Inc | 2017-10-10 | 10 percent owner | |
Zosano Pharma Corp | 2015-01-26 | 10 percent owner | |
Achaogen Inc | 2016-12-19 | 10 percent owner | |
Xtera Communications Inc | 2016-10-11 | 10 percent owner | |
Sorrento Tech Inc | 2016-09-21 | 10 percent owner | |
Interleukin Genetics Inc | 2016-07-29 | 10 percent owner | |
Opower Inc | 2016-06-14 | 10 percent owner | |
TriVascular Technologies Inc | 2016-02-03 | 10 percent owner | |
Epizyme Inc | 2016-01-12 | 10 percent owner | |
Supernus Pharmaceuticals Inc | 2015-06-17 | 10 percent owner | |
Avalo Therapeutics Inc | 2015-10-14 | 10 percent owner | |
Vitae Pharmaceuticals Inc | 2015-07-01 | 10 percent owner | |
Champions Oncology Inc | 2015-03-11 | 10 percent owner | |
Box Inc | 2015-01-22 | 10 percent owner | |
Boingo Wireless Inc | 2014-12-19 | 10 percent owner | |
Trevena Inc | 2014-01-30 | 10 percent owner | |
Tableau Software Inc | 2014-12-02 | 10 percent owner | |
Cvent Inc | 2014-11-25 | 10 percent owner | |
Dermira Inc | 2014-10-08 | 10 percent owner | |
Sunesis Pharmaceuticals Inc | 2014-08-27 | 10 percent owner | |
Loxo Oncology Inc | 2014-08-06 | 10 percent owner | |
Aerohive Networks Inc | 2014-04-02 | 10 percent owner | |
ChannelAdvisor Corp | 2013-05-22 | 10 percent owner | |
Catalyst Biosciences Inc | 2013-12-05 | 10 percent owner | |
Xoom Corp | 2013-10-29 | 10 percent owner | |
Clovis Oncology Inc | 2011-11-21 | 10 percent owner | |
Workday Inc | 2012-10-11 | 10 percent owner | |
Millennial Media Inc | 2012-10-29 | 10 percent owner | |
Vonage Holdings Corp | 2006-05-23 | director & 10 percent owner | |
InnerWorkings Inc | 2012-05-30 | director | |
Amicus Therapeutics Inc | 2012-03-07 | 10 percent owner | |
Echo Global Logistics Inc | 2012-03-05 | director & 10 percent owner | |
Inteliquent Inc | 2011-11-16 | director | |
Glu Mobile Inc | 2011-08-08 | 10 percent owner | |
ARYx Therapeutics Inc | 2011-03-10 | 10 percent owner | |
Financial Engines Inc | 2010-08-30 | 10 percent owner | |
Voltari Corp | 2010-06-23 | 10 percent owner | |
W World Corp | 2009-05-08 | 10 percent owner | |
Paratek Pharmaceuticals Inc | 2006-05-09 | 10 percent owner | |
DZS Inc | 2007-08-14 | 10 percent owner | |
Aradigm Corp | 2004-02-20 | 10 percent owner | |
Viracta Therapeutics Inc | 2009-04-03 | 10 percent owner | |
Yumanity Therapeutics Inc | 2016-02-10 | 10 percent owner | |
Tempest Therapeutics Inc | 2018-12-07 | 10 percent owner | |
Berkshire Grey Inc | 2023-07-20 | director | |
NextNav Inc | 2021-10-28 | director | |
ZeroFox Holdings Inc | 2022-08-03 | director | |
Kineta Inc | 2016-02-10 | 10 percent owner | |
Genocea Biosciences Inc | 2018-01-19 | 10 percent owner | |
Revolution Acceleration Acquisition Corp | 2023-07-20 | director |
Peter J Barris Latest Holdings Summary
Peter J Barris currently owns a total of 34 stocks. Among these stocks, Peter J Barris owns 10,422,179 shares of Tesaro Inc (TSRO) as of March 6, 2018, with a value of $781 Million and a weighting of 31.33%. Peter J Barris owns 13,610,551 shares of iShares Indl/Office Real Estate Capped (FNIO) as of April 30, 2012, with a value of $434 Million and a weighting of 17.41%. Peter J Barris also owns 7,716,055 shares of Supernus Pharmaceuticals Inc (SUPN) as of June 17, 2015, with a value of $230 Million and a weighting of 9.21%. The other 31 stocks Rhythm Pharmaceuticals Inc (RYTM) , Ra Pharmaceuticals Inc (RARX) , Mirum Pharmaceuticals Inc (MIRM) , Adaptimmune Therapeutics PLC (ADAP) , Ardelyx Inc (ARDX) , Echo Global Logistics Inc (ECHO) , Boingo Wireless Inc (WIFI) , Amicus Therapeutics Inc (FOLD) , AVEO Pharmaceuticals Inc (AVEO) , Liquidia Corp (LQDA) , Mersana Therapeutics Inc (MRSN) , GlycoMimetics Inc (GLYC) , Millennial Media Inc (MM) , InnerWorkings Inc (INWK) , Senseonics Holdings Inc (SENS) , Trevi Therapeutics Inc (TRVI) , Epizyme Inc (EPZM) , Tableau Software Inc (DATA) , Surface Oncology Inc (SURF) , Regulus Therapeutics Inc (RGLS) , Groupon Inc (GRPN) , Catalyst Biosciences Inc (CBIO) , Dermira Inc (DERM) , Interleukin Genetics Inc (ILIU) , Achaogen Inc (AKAOQ) , Clovis Oncology Inc (CLVSQ) , TRACON Pharmaceuticals Inc (TCON) , Genocea Biosciences Inc (GNCAQ) , Novation Companies Inc (NOVCQ) , ARCA biopharma Inc (ABIO) , Appian Corp (APPN) have a combined weighting of 42.05% among all his current holdings.
Latest Holdings of Peter J Barris
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
TSRO | Tesaro Inc | 2018-03-06 | 10,422,179 | 74.96 | 781,246,538 |
FNIO | iShares Indl/Office Real Estate Capped | 2012-04-30 | 13,610,551 | 31.89 | 434,040,471 |
SUPN | Supernus Pharmaceuticals Inc | 2015-06-17 | 7,716,055 | 29.76 | 229,629,797 |
RYTM | Rhythm Pharmaceuticals Inc | 2017-10-10 | 4,909,956 | 40.07 | 196,717,387 |
RARX | Ra Pharmaceuticals Inc | 2016-10-31 | 3,490,073 | 47.99 | 167,488,603 |
MIRM | Mirum Pharmaceuticals Inc | 2019-07-22 | 4,186,243 | 24.64 | 103,128,096 |
ADAP | Adaptimmune Therapeutics PLC | 2018-09-07 | 94,978,668 | 1.03 | 97,353,135 |
ARDX | Ardelyx Inc | 2016-07-18 | 14,084,162 | 6.74 | 94,856,831 |
ECHO | Echo Global Logistics Inc | 2012-03-05 | 1,420,901 | 48.24 | 68,544,264 |
WIFI | Boingo Wireless Inc | 2013-12-11 | 4,469,108 | 13.99 | 62,522,821 |
FOLD | Amicus Therapeutics Inc | 2012-03-07 | 5,650,340 | 10.59 | 59,808,849 |
AVEO | AVEO Pharmaceuticals Inc | 2019-04-08 | 2,524,387 | 15.00 | 37,865,805 |
LQDA | Liquidia Corp | 2018-07-30 | 2,484,870 | 13.73 | 34,118,756 |
MRSN | Mersana Therapeutics Inc | 2017-07-03 | 8,140,138 | 3.77 | 30,647,620 |
GLYC | GlycoMimetics Inc | 2018-05-10 | 9,089,041 | 2.23 | 20,268,561 |
MM | Millennial Media Inc | 2012-10-29 | 8,196,614 | 1.75 | 14,344,075 |
INWK | InnerWorkings Inc | 2012-05-30 | 4,566,835 | 2.99 | 13,654,837 |
SENS | Senseonics Holdings Inc | 2017-12-08 | 30,936,643 | 0.44 | 13,582,733 |
TRVI | Trevi Therapeutics Inc | 2019-05-09 | 4,438,562 | 2.66 | 11,806,575 |
EPZM | Epizyme Inc | 2016-01-12 | 6,261,599 | 1.47 | 9,204,551 |
DATA | Tableau Software Inc | 2014-08-25 | 40,077 | 169.53 | 6,794,254 |
SURF | Surface Oncology Inc | 2018-04-23 | 3,312,877 | 1.07 | 3,544,778 |
RGLS | Regulus Therapeutics Inc | 2019-05-07 | 205,245 | 2.58 | 529,532 |
GRPN | Groupon Inc | 2019-12-26 | 42,476 | 10.19 | 432,983 |
CBIO | Catalyst Biosciences Inc | 2013-12-05 | 43,462 | 7.67 | 333,332 |
DERM | Dermira Inc | 2014-10-02 | 17,241 | 18.75 | 323,269 |
ILIU | Interleukin Genetics Inc | 2016-07-29 | 55,418,811 | 0.00 | 249,385 |
AKAOQ | Achaogen Inc | 2016-12-19 | 5,215,128 | 0.03 | 130,378 |
CLVSQ | Clovis Oncology Inc | 2011-11-21 | 3,419,671 | 0.02 | 51,295 |
TCON | TRACON Pharmaceuticals Inc | 2018-03-27 | 17,330 | 1.74 | 30,154 |
GNCAQ | Genocea Biosciences Inc | 2019-06-24 | 7,225,676 | 0.00 | 723 |
NOVCQ | Novation Companies Inc | 2006-05-15 | 1,225,179 | 0.00 | 123 |
ABIO | ARCA biopharma Inc | 2018-02-26 | 0 | 3.13 | 0 |
APPN | Appian Corp | 2017-11-27 | 0 | 36.61 | 0 |
Holding Weightings of Peter J Barris
Peter J Barris Form 4 Trading Tracker
According to the SEC Form 4 filings, Peter J Barris has made a total of 0 transactions in Tesaro Inc (TSRO) over the past 5 years. The most-recent trade in Tesaro Inc is the acquisition of 145,532 shares on March 6, 2018, which cost Peter J Barris around $8 Million.
According to the SEC Form 4 filings, Peter J Barris has made a total of 0 transactions in iShares Indl/Office Real Estate Capped (FNIO) over the past 5 years. The most-recent trade in iShares Indl/Office Real Estate Capped is the sale of 16,101 shares on April 30, 2012, which brought Peter J Barris around $427,160.
According to the SEC Form 4 filings, Peter J Barris has made a total of 0 transactions in Supernus Pharmaceuticals Inc (SUPN) over the past 5 years. The most-recent trade in Supernus Pharmaceuticals Inc is the sale of 111,881 shares on June 17, 2015, which brought Peter J Barris around $2 Million.
More details on Peter J Barris's insider transactions can be found in the Insider Trading History of Peter J Barris table.Insider Trading History of Peter J Barris
- 1
Peter J Barris Trading Performance
GuruFocus tracks the stock performance after each of Peter J Barris's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Peter J Barris is 8.04%. GuruFocus also compares Peter J Barris's trading performance to market benchmark return within the same time period. The performance of stocks bought by Peter J Barris within 3 months outperforms 25 times out of 48 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Peter J Barris's insider trading performs compared to the benchmark.
Performance of Peter J Barris
Average Relative Return
-14.7%
Outperforming Transactions
26%
1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
---|---|---|---|---|---|---|
Relative Return(%) | 6.76 | 8.04 | 6.96 | -14.7 | -25.51 | -23.17 |
Relative Return to S&P 500(%) | 6.17 | 4.99 | 0.96 | -26.56 | -36.99 | -35.89 |
Peter J Barris Ownership Network
Ownership Network List of Peter J Barris
Ownership Network Relation of Peter J Barris
Peter J Barris Owned Company Details
What does Sprout Social Inc do?
Who are the key executives at Sprout Social Inc?
Peter J Barris is the director & 10 percent owner of Sprout Social Inc. Other key executives at Sprout Social Inc include director & 10 percent owner & Chairman and CEO Justyn Russell Howard , President Ryan Paul Barretto , and director & 10 percent owner & Chief Technology Officer Rankin Aaron Edward Frederick .
Sprout Social Inc () Insider Trades Summary
Over the past 18 months, Peter J Barris made no insider transaction in Sprout Social Inc (). Other recent insider transactions involving Sprout Social Inc () include a net sale of 40,801 shares made by Preto Joseph Del , a net sale of 435,000 shares made by Justyn Russell Howard , and a net sale of 276,051 shares made by Rankin Aaron Edward Frederick .
In summary, during the past 3 months, insiders sold 251,540 shares of Sprout Social Inc () in total and bought 0 shares, with a net sale of 251,540 shares. During the past 18 months, 968,765 shares of Sprout Social Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 968,765 shares.
Sprout Social Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.
Sprout Social Inc Insider Transactions
Peter J Barris Mailing Address
Above is the net worth, insider trading, and ownership report for Peter J Barris. You might contact Peter J Barris via mailing address: 1119 St Paul Street, Baltimore Md 21202.